Senzime

More than half of all surgical procedures are performed on patients over 65 years of age. Due to ageing, the skin becomes more fragile because of a gradual loss of subcutaneous fat, causing skin to become more vulnerable to the damage that may be caused by conventional adhesives used in monitoring patches.

Senzime’s new TetraSensitive is the first EMG sensor designed specifically for neuromuscular monitoring of patients with sensitive and fragile skin. Its novel design combines advanced technology using an ultrasoft stretchable material and a flexible silver print to create a natural contact with the skin and eliminate discomfort. TetraSensitive is developed to provide superior adhesion without sharp edges, and the smart sizing design makes it ideal for different patient sizes. The TetraSensitive is protected by valid EU and US patent laws.

“Senzime continues to launch innovations to advance patient safety and help eliminate postoperative complications. We now offer the only complete portfolio of EMG sensors meeting pediatric, adult and skin-sensitive patient needs to the US and EU market,” commented Philip Siberg, CEO of Senzime.

The new disposable TetraSensitive EMG sensor is used with the portable TetraGraph quantitative neuromuscular monitor. The new product will be showcased at Anesthesiology 2023, the American Society of Anesthesiologists annual meeting, in San Francisco, October 13-17, and will be available for customer deliveries in US and European markets from early November 2023.